IMO a capital raising is imminent.A capital raising is a matter of when not if.NTA & earnings per secutity indicate to me sp is undervalued.The above are my opinions .DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%